This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Discovery Corporation Appoints Thomas L. Gallagher As President, Chief Operating Officer And General Counsel

Health Discovery Corporation (OTCBB: HDVY) is pleased to announce that Thomas L. Gallagher has been appointed by the Board of Directors as President, Chief Operating Officer and General Counsel effective immediately.

Mr. Gallagher started at Health Discovery Corporation in late November 2009, as Executive Vice President and Managing Director, Global IP Strategies. Since August 9, 2010, Thomas L. Gallagher assumed the duties of President, General Counsel and Principal Financial Officer, in addition to his current duties.

“Tom has provided outstanding leadership this past year across our entire business,” said Stephen D. Barnhill, M.D., Chairman and CEO of Health Discovery Corporation. “He possesses a unique combination of strong execution skills, solid business and legal judgment, and a keen sense of new business development and strategy,” said Dr. Barnhill.

“It’s been an exciting year for Health Discovery Corporation and I’ve enjoyed immensely working closely with Dr. Barnhill, the Board of Directors and our colleagues to help drive our business to new levels of success,” Mr. Gallagher said.

On October 20, 2010, the Board of Directors also approved the grant to Mr. Gallagher of 2,500,000 options to purchase common stock. The options are exercisable immediately at an exercise price of $0.19 per share (the closing price on the grant date) and expire ten years after the grant date. For calendar year 2010, Mr. Gallagher will receive a base salary of $120,000 and will be eligible to receive a bonus of $120,000. The Company will record a charge of $357,798 in the fourth quarter with respect to the option grant. For calendar year 2011, Mr. Gallagher and the Board of Directors expect to finalize his compensation package by year-end 2010.

On October 21, 2010, the Company held its annual meeting of shareholders. The results were certified by Corporate Stock Transfer, Inc., the Company’s transfer agent. At the meeting, the shareholders elected the following directors by the vote shown:






Stephen D. Barnhill, M.D. 76,206,370 3,180,924 78,170,700
D. Paul Graham 78,550,012 837,282 78,170,700
Joseph McKenzie, D.V.M. 78,586,687 800,607 78,170,700
Curtis G. Anderson 78,532,285 855,009 78,170,700

Broker non-votes occur when shares held by a broker are not voted with respect to a particular proposal because the broker has not received voting instructions from the beneficial owner and the broker lacks discretionary voting power to vote such shares. Under New York Stock Exchange Rules, a broker does not have discretionary authority to vote in the election of directors absent instructions from the beneficial owner.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.18 1.60%
FB $117.44 -0.95%
GOOG $692.33 -0.84%
TSLA $232.12 -4.00%
YHOO $36.02 -1.40%


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs